Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we’ll explain below. However, now that it’s down 76% from highs, the stock looks poised for upside. In our opinion, InMode has two major catalysts that could send shares notably higher in the blink of an eye. These two catalysts include the potential for an activist investor to take a stake in the company and push for buybacks or for InMode to finally make an acqui
Fixed Ophthalmic Examination System Market Business Growth 2021-2026: Johnson & Johnson , CSO ,Delta Electronics , Echo-Son , iVis Technologies – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Apr 5, 2021
Speaking on the occasion Shri DV Sadananda Gowda commended India’s capabilities as a global and reliable supplier of drugs and medical devices during the COVID-19 pandemic. Citing the recent UNCTAD report, he also pointed out India’s positive FDI growth even with a decline in FDI of 42% globally. Shri Gowda said, “As the pandemic exposed the global vulnerabilities of the supply chains in the pharmaceuticals sector, the Department of Pharmaceuticals launched the Production Linked Incentive Scheme for bulk drugs, with a financial outlay of ₹6,940 crores across 53 APIs over 6 years. For Medical Devices, another PLI scheme was announced with an outlay of ₹3,420. Such interventions & incentives have played an instrumental role in realizing Prime Minister’s vision of ‘Aatmanirbhar Bharat’, or India for the world.”
Govt allocates PLI scheme of Rs 6,940 Cr for bulk drugs & Rs 3,420 Cr for medical devices
Govt allocates PLI scheme of Rs 6,940 Cr for bulk drugs & Rs 3,420 Cr for medical devices
25 February 2021 | News Fulfilling the vision of Aatmanirbhar Bharat, the government has allocated over Rs. 10,000 crores in PLI scheme for bulk drugs and medical devices: DV Sadananda Gowda
Speaking at the inauguration ceremony of India Pharma 2021 & India Medical Devices 2021 organised by FICCI along with the Department of Pharmaceuticals, Ministry of Chemicals & Fertilisers, Government of India, and Invest India, DV Sadananda Gowda, Minister for Chemicals and Fertilisers, Government of India said, “ The Department of Pharmaceuticals launched the Production Linked Incentive Scheme for bulk drugs, with a financial outlay of Rs 6,940 crore across 53 APIs over six years. For medical devices, another PLI scheme was announced with an outlay of Rs 3,420 crore. The medical devices industry in I